Pigmented Villonodular Synovitis Imaging 

Pigmented Villonodular Synovitis Imaging 

No Results

No Results

processing….

Pigmented villonodular synovitis (PVNS) is a benign proliferative disorder of uncertain etiology that affects synovial lined joints, bursae, and tendon sheaths (see the images below). The disorder results in various degrees of villous and/or nodular changes in the affected structures. PVNS lesions are monoarticular or solitary. Polyarticular disease is uncommon but more likely in children. [1, 2, 3]  

PVNS lesions on histology demonstrate synovial cell proliferation, xanthomatous cell accumulation, hemosiderin deposition, and the presence of multinucleated giant cells. Numerous pathophysiologic mechanisms, including inflammation (multinucleated giant cells), response to antecedent trauma, repeated hemorrhage into the joint (hemosiderin), and disorders of lipid metabolism (xanthoma cells), have been proposed. [4]  

PVNS is overwhelmingly benign, with only a few cases of malignant transformation reported, but it may result in significant morbidity if left untreated. Pain, loss of function, and eventual joint destruction may result. The primary treatment options include surgical resection via synovectomy or radiation therapy. [5]  Recurrence is reduced with complete resection, and it is achieved more often with localized disease. Radiation therapy may be used as the primary treatment method or in concert with surgical excision.

Clinical information and plain radiographs are not always sufficient to establish a correct diagnosis. MRI findings are characteristic, but not pathognomonic, for this disorder. Rarely, biopsy is required to establish preoperative tissue diagnosis. Plain radiographs demonstrate signs similar to joint effusion or soft-tissue swelling. Calcifications are not a usual feature of PVNS. Rarely, foci of dystrophic calcification may be seen in an area of PVNS. (See the images below.) [6, 7]

Computed tomography (CT) scans demonstrate a hyperdense soft-tissue mass in the joint or tendon sheath. The hyperdensity of the mass is a reflection of repeated hemorrhage and of blood degradation products within the joint. [8, 6, 9]

MR images demonstrate various appearances ranging from low signal through isointense to hyperintense signals on spin-echo images, reflecting the presence of blood and its degradation products. Hemosiderin appears as low signal on T1- and T2-weighted images. Differentiating calcifications from hemosiderin-laden foci in the setting of PVNS may be difficult, and plain films should be used in this setting to confirm or deny the presence of calcifications. [7, 6]

A combination of plain films and MRI should be used in preoperative evaluation of a patient with PVNS. This combination yields an accurate diagnosis and maps out the extent of disease for the surgeon prior to treatment.

Two primary forms are described, including a diffuse form that affects the entire synovial lining of a joint, bursa, or tendon sheath, and a rare focal, or localized, form. The diffuse form typically involves the large joints (see the first 2 images below), while the localized form typically occurs around the small joints of the hands and feet (see the last 2 images below).

Neoplasia is the currently accepted underlying etiology, with empirical and genetic evidence supporting this theory. PVNS has demonstrated the capability of autonomous growth and rare malignant transformation. Several genetic studies have demonstrated associated cytogenetic aberrations, including rearrangement involving the CSF-1 and COL6a3 genes, as well as association with trisomy 5 and trisomy 7. [10, 11, 1] Not all cases are associated with such genetic anomalies, suggesting a multifactorial etiology for the disease.

PVNS is an uncommon disease. [12] Prevalence is approximately 9.2 cases of extra-articular and 1.8 cases of intra-articular disease per 1 million population. [1, 2] Localized lesions are more common than diffuse involvement, comprising 77% of total lesions in one review, with a 3.3:1 localized-to-diffuse predominance ratio. Diffuse PVNS affects predominantly large joints, with the knee being the most common (66-80%). [13] The hip, ankle, shoulder, and elbow follow in descending frequency. The localized intra-articular form of PVNS occurs almost exclusively within the knee. Tendon sheaths of the hand and wrist are affected more frequently, with the volar aspect of the index and long fingers being the most common sites of disease. Diffuse PVNS has nearly equal incidence in male and female patients, while the localized form demonstrates a female-to-male predominance ratio of 1.5-2:1. Diagnosis is more common between ages 20 and 50 years, with a median age of 30 years.

The localized form often appears around tendon sheaths, in which case it is termed giant cell tumor of the tendon sheath. It primarily affects the knee  (66–80% of cases) but also affects the hips, ankle, shoulder, and elbow. [2] Rarely, the localized form may develop around large joints. The term PVNS generally is used when the condition, in either diffuse or localized form, affects a joint. Imaging plays an important role in the diagnosis, treatment, and follow-up monitoring of the disorder.

Plain radiographs cannot confidently exclude effusion as a cause of symptoms, nor can they help determine the extent of disease.

CT scan findings invariably are diagnostic; however, CT scanning is hobbled by its inability to completely show the extent of disease and other pathology around or within the joint.

MRI findings are diagnostic in more than 95% of patients. Rarely, synovial osteochondromatosis (SOC) may demonstrate a similar appearance, and plain radiographs may be necessary to exclude SOC in the appropriate setting.

Findings on plain radiographs are not specific. (See the image below.)

In the diffuse form, pigmented villonodular synovitis (PVNS) presents as painless, monoarticular joint swelling. Findings of mineralization of the bones around the lesion are normal until late in the disease, with preservation of the cartilage space and no calcifications.

Well-corticated pressure erosions (saucerization) and cysts may occur on either side or both sides of the joint. Secondary degenerative changes may occur in the affected joint in long-standing disease, with concentric cartilage space narrowing, subchondral cyst, and osteophyte formation.

The diffuse form presents with joint effusion/soft-tissue swelling. Occasionally, the effusion is dense due to the presence of hemosiderin. The nodular form most commonly results in localized swelling of the palmar aspect of a finger.

 

CT scan findings are as follows:

Secondary to the presence of intracellular and extracellular hemosiderin, lesions have high attenuation and appear hyperdense on CT scans

Because of improved tissue contrast, CT scanning is valuable in delineating bone cysts and erosions

Affected synovium is hypervascular and generally enhances following administration of radiographic contrast

CT scanning is useful for needle biopsy guidance when a histologic diagnosis is required and is especially useful for preoperative planning

Radiographic contrast may be injected into the joint following joint aspiration. With contrast filling of the joint, findings demonstrate multiple, irregular, nodular filling defects of variable sizes. These produce the typical cobblestone appearance of the synovium seen on arthrography. [8, 6, 9]

MRI has become the imaging modality of choice in the evaluation of synovial and soft-tissue lesions. Pigmented villonodular synovitis (PVNS) demonstrates variable appearance on MRI, depending on the composition of the lesion and its relative proportions of hemosiderin, lipid, fibrous tissue, cyst formation, and cellular elements and on the imaging parameters. [6, 7, 14, 15, 16, 17, 18, 3]

Characteristic findings include nodular intra-articular masses that demonstrate low signal intensity on T1-, T2-, and proton density–weighted sequences (as in the images below). Low signal intensity is due to hemosiderin deposits within the affected tissue and is accentuated on T2-weighted sequences, most notably on gradient-recalled echo sequences. [1, 2]

Hemophilic arthropathy, synovial hemangioma, synovial chondromatosis, gout, and amyloid arthropathy may all present similarly on MRI.

The presence of fat signal also is apparent secondary to the presence of lipid-laden macrophages, resulting in focal regions of high signal intensity on T1-weighted images and intermediate signal on T2-weighted images.

Hyperplastic and hypervascular synovium enhances following intravascular administration of gadolinium chelates.

Bony erosions (when present) and extra-articular extension of the lesion are well demonstrated on MRI. MRI findings are not pathognomonic for PVNS, and similar findings may be seen in rheumatoid arthritis, hemophilic arthropathy, amyloid arthropathy, synovial osteochondromatosis, gout, and degenerative joint disease.

Bone scans do not play a significant or routine role in the diagnosis of pigmented villonodular synovitis (PVNS). On bone scan, the hypervascularity and areas of erosion may result in increased radionuclide uptake. Soft-tissue masses often demonstrate increased uptake on blood-pool images.

Positron emission tomography (PET) imaging is of similarly little utility in establishing the diagnosis or extent of involvement of PVNS. The lesions are generally hypermetabolic. Unsuspected lesions may be found during surveillance for neoplasia on PET scans.

PVNS and giant cell tumor of the tendon sheath (GCTTS) , according to a study by Broski et al, can be intensely hypermetabolic, mimicking musculoskeletal metastases on 18F-FDG PET/CT. [8]  PVNS displays as a focal FDG avid lesion, which can masquerade as a metastatic lesion, on PET-CT. [2]  

The finding of isolated hypermetabolic focus within a joint or bursa or along a tendon is nonspecific but has been a source of confusion in cases of neoplastic surveillance.

Steinmetz S, Rougemont AL, Peter R. Pigmented villonodular synovitis of the hip. EFORT Open Rev. 2016 Jun. 1 (6):260-266. [Medline].

Elumogo CO, Kochenderfer JN, Civelek AC, Bluemke DA. Pigmented villonodular synovitis mimics metastases on fluorine 18 fluorodeoxyglucose position emission tomography-computed tomography. Quant Imaging Med Surg. 2016 Apr. 6 (2):218-23. [Medline].

Nordemar D, Öberg J, Brosjö O, Skorpil M. Intra-Articular Synovial Sarcomas: Incidence and Differentiating Features from Localized Pigmented Villonodular Synovitis. Sarcoma. 2015. 2015:903873. [Medline].

Bertoni F, Unni KK, Beabout JW, Sim FH. Malignant giant cell tumor of the tendon sheaths and joints (malignant pigmented villonodular synovitis). Am J Surg Pathol. 1997 Feb. 21(2):153-63. [Medline].

Shabat S, Kollender Y, Merimsky O, et al. The use of surgery and yttrium 90 in the management of extensive and diffuse pigmented villonodular synovitis of large joints. Rheumatology (Oxford). 2002 Oct. 41(10):1113-8. [Medline].

Lang N, Yuan HS. Computed Tomography and Magnetic Resonance Manifestations of Spinal Pigmented Villonodular Synovitis. J Comput Assist Tomogr. 2015 Jul-Aug. 39 (4):601-6. [Medline].

Lynskey SJ, Pianta MJ. MRI and Thallium features of Pigmented Villonodular Synovitis and Giant Cell Tumours of Tendon Sheaths: A retrospective single centre study of imaging and literature review. Br J Radiol. 2015 Oct 6. 20150528. [Medline].

Broski SM, Murdoch NM, Skinner JA, Wenger DE. Pigmented Villonodular Synovitis: Potential Pitfall on Oncologic 18F-FDG PET/CT. Clin Nucl Med. 2015 Jul 7. [Medline].

Le WJ, Li MH, Yu Q, Shi HM. Pigmented villonodular synovitis of the temporomandibular joint: CT imaging findings. Clin Imaging. 2014 Jan-Feb. 38 (1):6-10. [Medline].

Cupp JS, Miller MA, Montgomery KD, et al. Translocation and expression of CSF1 in pigmented villonodular synovitis, tenosynovial giant cell tumor, rheumatoid arthritis and other reactive synovitides. Am J Surg Pathol. 2007 Jun. 31(6):970-6. [Medline].

Möller E, Mandahl N, Mertens F, Panagopoulos I. Molecular identification of COL6A3-CSF1 fusion transcripts in tenosynovial giant cell tumors. Genes Chromosomes Cancer. 2008 Jan. 47(1):21-5. [Medline].

Myers BW, Masi AT. Pigmented villonodular synovitis and tenosynovitis: a clinical epidemiologic study of 166 cases and literature review. Medicine (Baltimore). 1980 May. 59(3):223-38. [Medline].

Mukhopadhyay K, Smith M, Hughes PM. Multifocal PVNS in a child–followed over 25 years. Skeletal Radiol. 2006 Jul. 35(7):539-42. [Medline].

Bui-Mansfield LT, Youngberg RA, Coughlin W, Chooljian D. MRI of giant cell tumor of the tendon sheath in the cervical spine. J Comput Assist Tomogr. 1996 Jan-Feb. 20(1):113-5. [Medline].

Frassica FJ, Khanna JA, McCarthy EF. The role of MR imaging in soft tissue tumor evaluation: perspective of the orthopedic oncologist and musculoskeletal pathologist. Magn Reson Imaging Clin N Am. 2000 Nov. 8(4):915-27. [Medline].

Jelinek JS, Kransdorf MJ, Shmookler BM, et al. Giant cell tumor of the tendon sheath: MR findings in nine cases. AJR Am J Roentgenol. 1994 Apr. 162(4):919-22. [Medline].

Jelinek JS, Kransdorf MJ, Utz JA, et al. Imaging of pigmented villonodular synovitis with emphasis on MR imaging. AJR Am J Roentgenol. 1989 Feb. 152(2):337-42. [Medline].

Ugai K, Morimoto K. Magnetic resonance imaging of pigmented villonodular synovitis in subtalar joint. Report of a case. Clin Orthop. 1992 Oct. (283):281-4. [Medline].

John R McGrath, MD Resident Physician, Department of Radiology, University of Rochester Medical Center

John R McGrath, MD is a member of the following medical societies: American Roentgen Ray Society, Association of University Radiologists, Radiological Society of North America

Disclosure: Nothing to disclose.

Johnny U V Monu, MD, MS Professor of Imaging Sciences and Orthopedics, University of Rochester School of Medicine and Dentistry; Head and Program Director, Musculoskeletal Radiology, Department of Radiology, University of Rochester Strong Memorial Medical Center

Johnny U V Monu, MD, MS is a member of the following medical societies: Radiological Society of North America

Disclosure: Nothing to disclose.

Bernard D Coombs, MB, ChB, PhD Consulting Staff, Department of Specialist Rehabilitation Services, Hutt Valley District Health Board, New Zealand

Disclosure: Nothing to disclose.

Lynne S Steinbach, MD Professor of Radiology and Orthopedic Surgery, University of California, San Francisco, School of Medicine

Lynne S Steinbach, MD is a member of the following medical societies: American College of Radiology, International Skeletal Society, Radiological Society of North America

Disclosure: Nothing to disclose.

Felix S Chew, MD, MBA, MEd Professor, Department of Radiology, Vice Chairman for Academic Innovation, Section Head of Musculoskeletal Radiology, University of Washington School of Medicine

Felix S Chew, MD, MBA, MEd is a member of the following medical societies: American Roentgen Ray Society, Association of University Radiologists, Radiological Society of North America

Disclosure: Nothing to disclose.

Amilcare Gentili, MD Professor of Clinical Radiology, University of California, San Diego, School of Medicine; Consulting Staff, Department of Radiology, Thornton Hospital; Chief of Radiology, San Diego Veterans Affairs Healthcare System

Amilcare Gentili, MD is a member of the following medical societies: American Roentgen Ray Society, Radiological Society of North America, Society of Skeletal Radiology

Disclosure: Nothing to disclose.

We wish to thank Simone Elvey, MD, for her previous contributions to this article.

Pigmented Villonodular Synovitis Imaging 

Research & References of Pigmented Villonodular Synovitis Imaging |A&C Accounting And Tax Services
Source